655 related articles for article (PubMed ID: 16688757)
1. Stochastic cancer progression driven by non-clonal chromosome aberrations.
Heng HH; Stevens JB; Liu G; Bremer SW; Ye KJ; Reddy PV; Wu GS; Wang YA; Tainsky MA; Ye CJ
J Cell Physiol; 2006 Aug; 208(2):461-72. PubMed ID: 16688757
[TBL] [Abstract][Full Text] [Related]
2. Cancer progression by non-clonal chromosome aberrations.
Heng HH; Bremer SW; Stevens J; Ye KJ; Miller F; Liu G; Ye CJ
J Cell Biochem; 2006 Aug; 98(6):1424-35. PubMed ID: 16676347
[TBL] [Abstract][Full Text] [Related]
3. The dynamics of cancer chromosomes and genomes.
Ye CJ; Liu G; Bremer SW; Heng HH
Cytogenet Genome Res; 2007; 118(2-4):237-46. PubMed ID: 18000376
[TBL] [Abstract][Full Text] [Related]
4. Clonal and non-clonal chromosome aberrations and genome variation and aberration.
Heng HH; Liu G; Bremer S; Ye KJ; Stevens J; Ye CJ
Genome; 2006 Mar; 49(3):195-204. PubMed ID: 16604101
[TBL] [Abstract][Full Text] [Related]
5. On the karyotypic origin and evolution of cancer cells.
Nicholson JM; Duesberg P
Cancer Genet Cytogenet; 2009 Oct; 194(2):96-110. PubMed ID: 19781442
[TBL] [Abstract][Full Text] [Related]
6. Karyotypic complexity of the NCI-60 drug-screening panel.
Roschke AV; Tonon G; Gehlhaus KS; McTyre N; Bussey KJ; Lababidi S; Scudiero DA; Weinstein JN; Kirsch IR
Cancer Res; 2003 Dec; 63(24):8634-47. PubMed ID: 14695175
[TBL] [Abstract][Full Text] [Related]
7. Distinct profiles of critically short telomeres are a key determinant of different chromosome aberrations in immortalized human cells: whole-genome evidence from multiple cell lines.
Deng W; Tsao SW; Guan XY; Lucas JN; Si HX; Leung CS; Mak P; Wang LD; Cheung AL
Oncogene; 2004 Dec; 23(56):9090-101. PubMed ID: 15489894
[TBL] [Abstract][Full Text] [Related]
8. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma.
Höglund M; Säll T; Heim S; Mitelman F; Mandahl N; Fadl-Elmula I
Cancer Res; 2001 Nov; 61(22):8241-6. PubMed ID: 11719456
[TBL] [Abstract][Full Text] [Related]
9. Karyotypic evolution and tumor progression in head and neck squamous cell carcinomas.
Jin Y; Jin C; Lv M; Tsao SW; Zhu J; Wennerberg J; Mertens F; Kwong YL
Cancer Genet Cytogenet; 2005 Jan; 156(1):1-7. PubMed ID: 15588849
[TBL] [Abstract][Full Text] [Related]
10. Cancer-causing karyotypes: chromosomal equilibria between destabilizing aneuploidy and stabilizing selection for oncogenic function.
Li L; McCormack AA; Nicholson JM; Fabarius A; Hehlmann R; Sachs RK; Duesberg PH
Cancer Genet Cytogenet; 2009 Jan; 188(1):1-25. PubMed ID: 19061776
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
[TBL] [Abstract][Full Text] [Related]
12. Genetic instability and divergence of clonal populations in colon cancer cells in vitro.
Masramon L; Vendrell E; Tarafa G; Capellà G; Miró R; Ribas M; Peinado MA
J Cell Sci; 2006 Apr; 119(Pt 8):1477-82. PubMed ID: 16551697
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic analysis of tumor clonality.
Teixeira MR; Heim S
Adv Cancer Res; 2011; 112():127-49. PubMed ID: 21925303
[TBL] [Abstract][Full Text] [Related]
14. How aneuploidy may cause cancer and genetic instability.
Duesberg P; Rasnick D; Li R; Winters L; Rausch C; Hehlmann R
Anticancer Res; 1999; 19(6A):4887-906. PubMed ID: 10697602
[TBL] [Abstract][Full Text] [Related]
15. Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer.
Ye CJ; Stevens JB; Liu G; Bremer SW; Jaiswal AS; Ye KJ; Lin MF; Lawrenson L; Lancaster WD; Kurkinen M; Liao JD; Gairola CG; Shekhar MP; Narayan S; Miller FR; Heng HH
J Cell Physiol; 2009 May; 219(2):288-300. PubMed ID: 19115235
[TBL] [Abstract][Full Text] [Related]
16. A model for genetic complementation controlling the chromosomal abnormalities and loss of heterozygosity formation in cancer.
Nestor AL; Hollopeter SL; Matsui SI; Allison D
Cytogenet Genome Res; 2007; 116(4):235-47. PubMed ID: 17431320
[TBL] [Abstract][Full Text] [Related]
17. Chromosome aberrations in solid tumors have a stochastic nature.
Castro MA; Onsten TG; Moreira JC; de Almeida RM
Mutat Res; 2006 Aug; 600(1-2):150-64. PubMed ID: 16814328
[TBL] [Abstract][Full Text] [Related]
18. Cancer genome sequencing: the challenges ahead.
Heng HH
Bioessays; 2007 Aug; 29(8):783-94. PubMed ID: 17621658
[TBL] [Abstract][Full Text] [Related]
19. Dissecting karyotypic patterns in colorectal tumors: two distinct but overlapping pathways in the adenoma-carcinoma transition.
Höglund M; Gisselsson D; Hansen GB; Säll T; Mitelman F; Nilbert M
Cancer Res; 2002 Oct; 62(20):5939-46. PubMed ID: 12384560
[TBL] [Abstract][Full Text] [Related]
20. Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors.
Foukakis T; Thoppe SR; Lagercrantz S; Dwight T; Weng WH; Svensson A; Höög A; Zedenius J; Wallin G; Lui WO; Larsson C
Int J Oncol; 2005 Jan; 26(1):141-9. PubMed ID: 15586234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
